Oxford Immunotec to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 23, 2016 15:27 pm UTC| Business
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 23, 2016 -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for...
Feb 23, 2016 15:03 pm UTC| Business
NEW YORK, Feb. 23, 2016 -- Medley Management Inc. (NYSE:MDLY), a credit-focused asset management firm, today announced that it committed over $1 billion of capital to U.S. middle market companies throughout 2015. ...
Canon Solutions America Rolls Out Marketing Strategy to Increase Access to Large Format Color
Feb 23, 2016 15:02 pm UTC| Business
MELVILLE, N.Y., Feb. 23, 2016 -- Canon Solutions America, Inc., a wholly owned subsidiary of Canon U.S.A., Inc., recently expanded its strategy of making mid-volume production color accessible to a much broader segment of...
Feb 23, 2016 15:00 pm UTC| Business
BOSTON, Feb. 23, 2016 -- DALBAR, Inc. announced the Top 5 Quality Rankings across the three most important customer touchpoints of financial services companies: Contact Centers, Statements and Websites, based on 2015...
TransPerfect Posts Record Sales for GlobalLink Technology in 2015
Feb 23, 2016 15:00 pm UTC| Business
NEW YORK, Feb. 23, 2016 -- TransPerfect, the world’s leading provider of language services and technology solutions for global business, today announced that year-end sales totals for its GlobalLink technology were the...
The Andersons, Inc. (Nasdaq: ANDE) to Ring The Nasdaq Stock Market Opening Bell
Feb 23, 2016 15:00 pm UTC| Business
ADVISORY, Feb. 23, 2016 -- What:The Andersons, Inc. (Nasdaq:ANDE), a diversified company rooted in agriculture conducting business across North America in the grain, ethanol, plant nutrient and rail sectors, will...
CytomX Therapeutics, Inc. (Nasdaq:CTMX) to Ring The Nasdaq Stock Market Closing Bell
Feb 23, 2016 15:00 pm UTC| Business
ADVISORY, Feb. 23, 2016 -- What:CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will visit the Nasdaq MarketSite in...